Skip to main content
Top
Published in: BMC Pregnancy and Childbirth 1/2007

Open Access 01-12-2007 | Research article

Metabolic Syndrome features and risk of neural tube defects

Authors: Joel G Ray, Miles D Thompson, Marian J Vermeulen, Chris Meier, Philip R Wyatt, Pui-Yuen Wong, Anne M Summers, Sandra A Farrell, David EC Cole

Published in: BMC Pregnancy and Childbirth | Issue 1/2007

Login to get access

Abstract

Background

Maternal obesity and pre-pregnancy diabetes mellitus, features of the metabolic syndrome (MetSyn), are individual risk factors for neural tube defects (NTD). Whether they, in combination with additional features of MetSyn, alter this risk is not known. We evaluated the risk of NTD in association with maternal features of the MetSyn.

Methods

We used a population-based case-control study design in the province of Ontario, Canada. Cases and controls were derived from women who underwent antenatal maternal screening (MSS) at 15 to 20 weeks' gestation. There were 89 maternal cases with, and 434 controls without, an NTD-affected singleton pregnancy. Maternal features of MetSyn were defined by the presence of pre-pregnancy diabetes mellitus, body weight ≥ 90th centile among controls, non-white ethnicity and/or serum highly sensitive C-reactive protein (hsCRP) ≥ 75th centile of controls. Since hsCRP naturally increases in pregnancy, analyses were performed with, and without, the inclusion of hsCRP in the model.

Results

Mean hsCRP concentrations were exceptionally high among study cases and controls (6.1 and 6.4 mg/L, respectively). When hsCRP was excluded from the model, the adjusted odds ratios for NTD were 1.9 (95% confidence interval 1.1–3.4) in the presence 1 feature of MetSyn, and 6.1 (1.1–32.9) in the presence of 2 or more features. When hsCRP was included, the respective risk estimates were attenuated to 1.6 (0.88–2.8) and 3.1 (1.2–8.3).

Conclusion

We found about 2-fold and 6-fold higher risk for NTD in the presence 1, and 2 or more features, of the metabolic syndrome, respectively. It is not clear whether this risk is altered by the presence of a high serum hsCRP concentration.
Literature
1.
go back to reference Lumley J, Watson L, Watson M, Bower C: Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev. 2001, CD001056- Lumley J, Watson L, Watson M, Bower C: Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev. 2001, CD001056-
2.
go back to reference Ray JG, Wyatt PR, Vermeulen MJ, Meier C, Cole DE: Greater maternal weight and the ongoing risk of neural tube defects after folic acid flour fortification. Obstet Gynecol. 2005, 105: 261-5.CrossRefPubMed Ray JG, Wyatt PR, Vermeulen MJ, Meier C, Cole DE: Greater maternal weight and the ongoing risk of neural tube defects after folic acid flour fortification. Obstet Gynecol. 2005, 105: 261-5.CrossRefPubMed
3.
go back to reference Loeken MR: Current perspectives on the causes of neural tube defects resulting from diabetic pregnancy. Am J Med Genet C Semin Med Genet. 2005, 135: 77-87.CrossRef Loeken MR: Current perspectives on the causes of neural tube defects resulting from diabetic pregnancy. Am J Med Genet C Semin Med Genet. 2005, 135: 77-87.CrossRef
4.
go back to reference Mugo M, Sowers JR: Metabolic syndrome: implications of race and ethnicity. Ethn Dis. 2004, 14: 26-31. Mugo M, Sowers JR: Metabolic syndrome: implications of race and ethnicity. Ethn Dis. 2004, 14: 26-31.
5.
go back to reference Reisin E, Alpert MA: Definition of the metabolic syndrome: current proposals and controversies. Am J Med Sci. 2005, 330: 269-72. 10.1097/00000441-200512000-00003.CrossRefPubMed Reisin E, Alpert MA: Definition of the metabolic syndrome: current proposals and controversies. Am J Med Sci. 2005, 330: 269-72. 10.1097/00000441-200512000-00003.CrossRefPubMed
6.
go back to reference Tanuseputro P, Manuel DG, Leung M, Nguyen K, Johansen H: Canadian Cardiovascular Outcomes Research Team. Risk factors for cardiovascular disease in Canada. Can J Cardiol. 2003, 19: 1249-59.PubMed Tanuseputro P, Manuel DG, Leung M, Nguyen K, Johansen H: Canadian Cardiovascular Outcomes Research Team. Risk factors for cardiovascular disease in Canada. Can J Cardiol. 2003, 19: 1249-59.PubMed
7.
go back to reference Ogden CL, Flegal KM, Carroll MD, Johnson CL: Prevalence and trends in overweight among US children and adolescents, 1999–2000. JAMA. 2002, 288: 1728-32. 10.1001/jama.288.14.1728.CrossRefPubMed Ogden CL, Flegal KM, Carroll MD, Johnson CL: Prevalence and trends in overweight among US children and adolescents, 1999–2000. JAMA. 2002, 288: 1728-32. 10.1001/jama.288.14.1728.CrossRefPubMed
8.
go back to reference Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002, 287: 356-9. 10.1001/jama.287.3.356.CrossRefPubMed Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002, 287: 356-9. 10.1001/jama.287.3.356.CrossRefPubMed
9.
go back to reference Ray JG, Meier C, Vermeulen MJ, Boss S, Wyatt PR, Cole DE: Association of neural tube defects and folic acid food fortification in Canada. Lancet. 2002, 360: 2047-8. 10.1016/S0140-6736(02)11994-5.CrossRefPubMed Ray JG, Meier C, Vermeulen MJ, Boss S, Wyatt PR, Cole DE: Association of neural tube defects and folic acid food fortification in Canada. Lancet. 2002, 360: 2047-8. 10.1016/S0140-6736(02)11994-5.CrossRefPubMed
10.
go back to reference Statistics Canada: Income in Canada 2000. Ottawa: Statistics Canada, Catalogue No. 75-202 XIE. 2002 Statistics Canada: Income in Canada 2000. Ottawa: Statistics Canada, Catalogue No. 75-202 XIE. 2002
11.
go back to reference Belo L, Santos-Silva A, Rocha S, Caslake M, Cooney J, Pereira-Leite L, Quintanilha A, Rebelo I: Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy. Eur J Obstet Gynecol Reprod Biol. 2005, 123: 46-51. 10.1016/j.ejogrb.2005.02.022.CrossRefPubMed Belo L, Santos-Silva A, Rocha S, Caslake M, Cooney J, Pereira-Leite L, Quintanilha A, Rebelo I: Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy. Eur J Obstet Gynecol Reprod Biol. 2005, 123: 46-51. 10.1016/j.ejogrb.2005.02.022.CrossRefPubMed
12.
go back to reference Engstrom JL, Paterson SA, Doherty A, Trabulsi M, Speer KL: Accuracy of self-reported height and weight in women: an integrative review of the literature. J Midwifery Womens Health. 2003, 48: 338-45. 10.1016/S1526-9523(03)00281-2.CrossRefPubMed Engstrom JL, Paterson SA, Doherty A, Trabulsi M, Speer KL: Accuracy of self-reported height and weight in women: an integrative review of the literature. J Midwifery Womens Health. 2003, 48: 338-45. 10.1016/S1526-9523(03)00281-2.CrossRefPubMed
13.
go back to reference Tomeo CA, Rich-Edwards JW, Michels KB, Berkey CS, Hunter DJ, Frazier AL, Willett WC, Buka SL: Reproducibility and validity of maternal recall of pregnancy-related events. Epidemiology. 1999, 10: 774-7. 10.1097/00001648-199911000-00022.CrossRefPubMed Tomeo CA, Rich-Edwards JW, Michels KB, Berkey CS, Hunter DJ, Frazier AL, Willett WC, Buka SL: Reproducibility and validity of maternal recall of pregnancy-related events. Epidemiology. 1999, 10: 774-7. 10.1097/00001648-199911000-00022.CrossRefPubMed
14.
go back to reference Florey Cdu V: The use and interpretation of ponderal index and other weight-height ratios in epidemiological studies. J Chronic Dis. 1970, 23: 93-103. 10.1016/0021-9681(70)90068-8.CrossRefPubMed Florey Cdu V: The use and interpretation of ponderal index and other weight-height ratios in epidemiological studies. J Chronic Dis. 1970, 23: 93-103. 10.1016/0021-9681(70)90068-8.CrossRefPubMed
15.
go back to reference Watson PE, Watson ID, Batt RD: Obesity indices. Am J Clin Nutr. 1979, 32: 736-7.PubMed Watson PE, Watson ID, Batt RD: Obesity indices. Am J Clin Nutr. 1979, 32: 736-7.PubMed
16.
go back to reference Abrams B, Carmichael S, Selvin S: Factors associated with the pattern of maternal weight gain during pregnancy. Obstet Gynecol. 1995, 86: 170-6. 10.1016/0029-7844(95)00119-C.CrossRefPubMed Abrams B, Carmichael S, Selvin S: Factors associated with the pattern of maternal weight gain during pregnancy. Obstet Gynecol. 1995, 86: 170-6. 10.1016/0029-7844(95)00119-C.CrossRefPubMed
17.
go back to reference Mugo M, Sowers JR: Metabolic syndrome: implications of race and ethnicity. Ethn Dis. 2004, 14: 26-31. Mugo M, Sowers JR: Metabolic syndrome: implications of race and ethnicity. Ethn Dis. 2004, 14: 26-31.
18.
go back to reference Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA, Kelemen L, Yi C, Lonn E, Gerstein H, Hegele RA, McQueen M: Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet. 2000, 356: 279-84. 10.1016/S0140-6736(00)02502-2.CrossRefPubMed Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA, Kelemen L, Yi C, Lonn E, Gerstein H, Hegele RA, McQueen M: Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet. 2000, 356: 279-84. 10.1016/S0140-6736(00)02502-2.CrossRefPubMed
19.
go back to reference Ray JG, Vermeulen MJ, Meier C, Cole DE, Wyatt PR: Maternal ethnicity and risk of neural tube defects: a population-based study. CMAJ. 2004, 171: 343-5.CrossRefPubMedPubMedCentral Ray JG, Vermeulen MJ, Meier C, Cole DE, Wyatt PR: Maternal ethnicity and risk of neural tube defects: a population-based study. CMAJ. 2004, 171: 343-5.CrossRefPubMedPubMedCentral
20.
go back to reference Ray JG, Singh G, Burrows RF: Evidence for suboptimal use of periconceptional folic acid supplements globally. BJOG. 2004, 111: 399-408. 10.1111/j.1471-0528.2004.00115.x.CrossRefPubMed Ray JG, Singh G, Burrows RF: Evidence for suboptimal use of periconceptional folic acid supplements globally. BJOG. 2004, 111: 399-408. 10.1111/j.1471-0528.2004.00115.x.CrossRefPubMed
21.
go back to reference Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB, Wilson PW: C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation. 2004, 110: 380-5. 10.1161/01.CIR.0000136581.59584.0E.CrossRefPubMed Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB, Wilson PW: C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation. 2004, 110: 380-5. 10.1161/01.CIR.0000136581.59584.0E.CrossRefPubMed
22.
go back to reference Shaw GM, Quach T, Nelson V, Carmichael SL, Schaffer DM, Selvin S, Yang W: Neural tube defects associated with maternal periconceptional dietary intake of simple sugars and glycemic index. Am J Clin Nutr. 2003, 78: 972-8.PubMed Shaw GM, Quach T, Nelson V, Carmichael SL, Schaffer DM, Selvin S, Yang W: Neural tube defects associated with maternal periconceptional dietary intake of simple sugars and glycemic index. Am J Clin Nutr. 2003, 78: 972-8.PubMed
23.
go back to reference Carmichael SL, Shaw GM, Neri E, Schaffer DM, Selvin S: Physical activity and risk of neural tube defects. Matern Child Health J. 2002, 6: 151-7. 10.1023/A:1019722011688.CrossRefPubMed Carmichael SL, Shaw GM, Neri E, Schaffer DM, Selvin S: Physical activity and risk of neural tube defects. Matern Child Health J. 2002, 6: 151-7. 10.1023/A:1019722011688.CrossRefPubMed
24.
go back to reference Ray JG, Diamond P, Singh G, Bell CM: Brief overview of maternal triglycerides as a risk factor for pre-eclampsia. BJOG. 2006, 113: 379-86. 10.1111/j.1471-0528.2006.00889.x.CrossRefPubMed Ray JG, Diamond P, Singh G, Bell CM: Brief overview of maternal triglycerides as a risk factor for pre-eclampsia. BJOG. 2006, 113: 379-86. 10.1111/j.1471-0528.2006.00889.x.CrossRefPubMed
25.
go back to reference Scholl TO, Johnson WG: Folic acid: influence on the outcome of pregnancy. Am J Clin Nutr. 2000, 71: 1295S-303S.PubMed Scholl TO, Johnson WG: Folic acid: influence on the outcome of pregnancy. Am J Clin Nutr. 2000, 71: 1295S-303S.PubMed
26.
go back to reference Pritchett AM, Foreyt JP, Mann DL: Treatment of the metabolic syndrome: the impact of lifestyle modification. Curr Atheroscler Rep. 2005, 7: 95-102. 10.1007/s11883-005-0030-4.CrossRefPubMed Pritchett AM, Foreyt JP, Mann DL: Treatment of the metabolic syndrome: the impact of lifestyle modification. Curr Atheroscler Rep. 2005, 7: 95-102. 10.1007/s11883-005-0030-4.CrossRefPubMed
Metadata
Title
Metabolic Syndrome features and risk of neural tube defects
Authors
Joel G Ray
Miles D Thompson
Marian J Vermeulen
Chris Meier
Philip R Wyatt
Pui-Yuen Wong
Anne M Summers
Sandra A Farrell
David EC Cole
Publication date
01-12-2007
Publisher
BioMed Central
Published in
BMC Pregnancy and Childbirth / Issue 1/2007
Electronic ISSN: 1471-2393
DOI
https://doi.org/10.1186/1471-2393-7-21

Other articles of this Issue 1/2007

BMC Pregnancy and Childbirth 1/2007 Go to the issue